Cargando…
The “Sweet Spot” of Targeting Tumor Metabolism in Ovarian Cancers
SIMPLE SUMMARY: Ovarian cancer is the most lethal gynecologic malignancy. While most patients will initially respond to treatment, the majority will recur and develop chemoresistance. Therefore, we require a better understanding of how cancer cells evade chemotherapy, including the reprogramming of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562887/ https://www.ncbi.nlm.nih.gov/pubmed/36230617 http://dx.doi.org/10.3390/cancers14194696 |